Shares of Embecta Corp. (NASDAQ:EMBC – Get Free Report) traded down 3.2% during mid-day trading on Tuesday . The company traded as low as $14.13 and last traded at $14.28. 21,555 shares changed hands during trading, a decline of 95% from the average session volume of 422,949 shares. The stock had previously closed at $14.75.
Analyst Ratings Changes
Separately, Morgan Stanley lowered their price target on Embecta from $13.00 to $12.00 and set an “underweight” rating on the stock in a research report on Monday, July 15th.
Read Our Latest Research Report on Embecta
Embecta Trading Down 0.5 %
Embecta (NASDAQ:EMBC – Get Free Report) last announced its quarterly earnings data on Friday, August 9th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.28. Embecta had a net margin of 6.20% and a negative return on equity of 18.42%. The business had revenue of $272.50 million for the quarter, compared to the consensus estimate of $267.44 million. During the same quarter last year, the company posted $0.69 earnings per share. Embecta’s quarterly revenue was down 4.8% on a year-over-year basis. Sell-side analysts forecast that Embecta Corp. will post 2.29 earnings per share for the current fiscal year.
Embecta Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Tuesday, August 27th will be paid a dividend of $0.15 per share. The ex-dividend date is Tuesday, August 27th. This represents a $0.60 dividend on an annualized basis and a yield of 4.07%. Embecta’s dividend payout ratio is currently 49.59%.
Hedge Funds Weigh In On Embecta
A number of hedge funds have recently made changes to their positions in the business. Iat Reinsurance Co. LTD. bought a new stake in Embecta in the second quarter valued at about $50,000. Bfsg LLC bought a new position in Embecta during the fourth quarter worth about $53,000. YHB Investment Advisors Inc. acquired a new stake in Embecta during the first quarter valued at approximately $56,000. Public Employees Retirement System of Ohio grew its stake in shares of Embecta by 42.7% in the 4th quarter. Public Employees Retirement System of Ohio now owns 3,259 shares of the company’s stock valued at $62,000 after purchasing an additional 975 shares during the period. Finally, CWM LLC raised its holdings in shares of Embecta by 773.8% in the 2nd quarter. CWM LLC now owns 9,079 shares of the company’s stock worth $113,000 after buying an additional 8,040 shares in the last quarter. Institutional investors and hedge funds own 93.83% of the company’s stock.
Embecta Company Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Read More
- Five stocks we like better than Embecta
- Energy and Oil Stocks Explained
- Conservative Portfolio: Strategies for Stability
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Unlocking Growth: Why Arcos Dorados Belongs in Your Portfolio
- How to Find Undervalued Stocks
- Forget Robotaxis: Electric Air Taxis are the Next Big Investment
Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.